Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development

Journal of the American Society of Nephrology

Volumn 18, Issue 6, 2007, Pages 1697-1708

  Wilkinson, Lorine ^a   Gilbert, Thierry ^a   Kinna, Genevieve ^a   Ruta, Leah Anne ^b   Pennisi, David ^a   Kett, Michelle ^b   Little, Melissa H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN CRIM1; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; BONE MORPHOGENETIC PROTEIN RECEPTOR; CRIM1 PROTEIN, MOUSE; CYSTINE; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE;

ALBUMINURIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; GLOMERULUS; HOMOZYGOTE; IMMUNOGOLD ELECTRON MICROSCOPY; IN VIVO STUDY; KIDNEY BLOOD VESSEL; KIDNEY DEVELOPMENT; MOUSE; NONHUMAN; OUTBRED STRAIN; PODOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; AGE; ANIMAL; C57BL MOUSE; CAPILLARY; CELL STRAIN COS1; CERCOPITHECUS; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GLOMERULUS FILTRATION RATE; IMMUNOELECTRON MICROSCOPY; MALE; MESANGIUM CELL; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; SIGNAL TRANSDUCTION; ULTRASTRUCTURE; VASCULARIZATION;

AGE FACTORS; ALBUMINURIA; ANIMALS; ANIMALS, OUTBRED STRAINS; BONE MORPHOGENETIC PROTEIN RECEPTORS; CAPILLARIES; CERCOPITHECUS AETHIOPS; COS CELLS; CYSTINE; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLOMERULAR FILTRATION RATE; KIDNEY GLOMERULUS; MALE; MESANGIAL CELLS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICROSCOPY, IMMUNOELECTRON; PODOCYTES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 34249902768     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006091012     Document Type: Article

References (37)

1. Wakelin SJ, Marson L, Howie SE, Garden J, Lamb JR, Forsythe JL: The role of vascular endothelial growth factor in the kidney in health and disease. Nephron Physiol 98: 73-79, 2004
2. Eremina V, Quaggin SE: The role of VEGF-A in glomerular development and function. Curr Opin Nephrol Hypertens 13: 9-15, 2004
3. Sariola H, Timpl R, von der Mark K, Mayne R, Fitch JM, Linsenmayer TF, Ekblom P: Dual origin of glomerular basement membrane. Dev Biol 101: 86-96, 1984
4. Ballermann BJ: Glomerular endothelial cell differentiation. Kidney Int 67: 1668-1671, 2005
5. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber HP, Kikkawa Y, Miner JH, Quaggin SE: Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707-716, 2003
6. Mattot V, Moons L, Lupu F, Chernavvsky D, Gomez RA, Collen D, Carmeliet P: Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice. J Am Soc Nephrol 13: 1548-1560, 2002
7. Eremina V, Cui S, Gerber H, Ferrara N, Haigh J, Nagy A, Ema M, Rossant J, Jothy S, Miner JH, Quaggin SE: Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 17: 724-735, 2006
8. Kolle G, Georgas K, Holmes GP, Little MH, Yamada T: CRIM1, a novel gene encoding a cysteine-rich repeat protein, is developmentally regulated and implicated in vertebrate CNS development and organogenesis. Mech Dev 90: 181-193, 2000
9. Georgas K, Bowles J, Yamada T, Koopman P, Little MH: Characterisation of Crim1 expression in the developing mouse urogenital tract reveals a sexually dimorphic gonadal expression pattern. Dev Dyn 219: 582-587, 2000
10. Lovicu FJ, Kolle G, Yamada T, Little MH, McAvoy JW: Expression of Crim1 during murine ocular development. Mech Dev 94: 261-265, 2000
11. Pennisi DJ, Wilkinson L, Kolle G, Sohaskey ML, Gillinder K, Piper MJ, McAvoy JW, Lovicu FJ, Little MH: Crim1(KST264/KST264) mice display a disruption of the Crim1 gene resulting in perinatal lethality with defects in multiple organ systems. Dev Dyn 236: 502-511, 2007
12. Wilkinson L, Kolle G, Wen D, Piper M, Scott J, Little M: CRIM1 regulates the rate of processing and delivery of bone morphogenetic proteins to the cell surface. J Biol Chem 278: 34181-34188, 2003
13. Glienke J, Sturz A, Menrad A, Thierauch KH: CRIM1 is involved in endothelial cell capillary formation in vitro and is expressed in blood vessels in vivo. Mech Dev 119: 165-175, 2002
14. Kinna G, Kolle G, Carter A, Key B, Lieschke GJ, Perkins A, Little MH: Knockdown of zebrafish crim1 results in a bent tail phenotype with defects in somite and vascular development. Mech Dev 123: 277-287, 2006
15. Miner JH, Patton BL, Lentz SI, Gilbert DJ, Snider WD, Jenkins NA, Copeland NG, Sanes JR: The laminin alpha chains: Expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform. J Cell Biol 137: 685-701, 1997
16. Gilbert T, Cibert C, Moreau E, Geraud G, Merlet-Benichou C: Early defect in branching morphogenesis of the ureteric bud in induced nephron deficit. Kidney Int 50: 783-795, 1996
17. Miner JH, Li C: Defective glomerulogenesis in the absence of laminin alpha5 demonstrates a developmental role for the kidney glomerular basement membrane. Dev Biol 217: 278-289, 2000
18. Miner JH, Cunningham J, Sanes JR: Roles of laminin in embryogenesis: Exencephaly, syndactyly, and placentopathy in mice lacking laminin alpha5 chain. J Cell Biol 143: 1713-1723, 1998
19. Brown LF, Berse B, Tognazzi K, Manseau EJ, Van de Water L, Senger DR, Dvorak HF, Rosen S: Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 42: 1457-1461, 1992
20. Robinson CJ, Stringer SE: The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 114: 853-865, 2001
21. Vitt UA, Hsu SY, Hsueh AJ: Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules. Mol Endocrinol 15: 681-694, 2001
22. Foster RR, Hole R, Anderson K, Satchell SC, Coward RJ, Mathieson PW, Gillatt DA, Saleem MA, Bates DO, Harper SJ: Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am J Physiol Renal Physiol 284: F1263-F1273, 2003
23. Tallquist MD, Soriano P, Klinghoffer RA: Growth factor signaling pathways in vascular development. Oncogene 18: 7917-7932, 1999
24. O'Leary JM, Hamilton JM, Deane CM, Valeyev NV, Sandell LJ, Downing AK: Solution structure and dynamics of a prototypical chordin-like cysteine-rich repeat (von Willebrand factor type C module) from collagen IIA. J Biol Chem 279: 53857-53866, 2004
25. Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y: Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 277: 36288-36295, 2002
26. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA: Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19: 225-268, 1998
27. Muller YA, Li B, Christinger HW, Wells JA, Cunningham BC, de Vos AM: Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site. Proc Natl Acad Sci U S A 94: 7192-7197, 1997
28. Ohkawara B, Iemura S, ten Dijke P, Ueno N: Action range of BMP is defined by its N-terminal basic amino acid core. Curr Biol 12: 205-209, 2002
29. Constam DB, Robertson EJ: Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. J Cell Biol 144: 139-149, 1999
30. Gregory KE, Ono RN, Charbonneau NL, Kuo CL, Keene DR, Bachinger HP, Sakai LY: The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix. J Biol Chem 280: 27970-27980, 2005
31. Piccolo S, Agius E, Lu B, Goodman S, Dale L, De Robertis EM: Cleavage of chordin by xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity. Cell 91: 407-416, 1997
32. Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepherd K, Jones RC, Jaenisch R: Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 122: 3537-3547, 1996
33. Leveen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C: Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8: 1875-1887, 1994
34. Soriano P: Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 8: 1888-1896, 1994
35. Dudley AT, Robertson EJ: Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev Dyn 208: 349-362, 1997
36. Vukicevic S, Basic V, Rogic D, Basic N, Shih MS, Shepard A, Jin D, Dattatreyamurty B, Jones W, Dorai H, Ryan S, Griffiths D, Maliakal J, Jelic M, Pastorcic M, Stavljenic A, Sampath TK: Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin Invest 102: 202-214, 1998
37. Hruska KA, Guo G, Wozniak M, Martin D, Miller S, Liapis H, Loveday K, Klahr S, Sampath TK, Morrissey J: Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 279: F130-F143, 2000